Home

OrbiMed Israel GP II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/08/02

Trade details

Type
Insider sale
Amount
$459,234
Shares · price
153,078 sh · $3.00 a share
Held after
2,105,909 sh
Trade date
23/07/31
Filed
23/08/02
Days to filing
2 days

Sold 6.8% of holdings

Share of holding sold
6.8%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/01~23/08/30

OrbiMed Israel GP II's recent trades

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $10M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $5.1M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $1M

    Filed 09/30

  • OrbiMed Israel GP II

    SellAdicet Bio

    $263.5K

    Filed 04/09

  • OrbiMed Israel GP II

    SellAdicet Bio

    $204.6K

    Filed 04/09